Deferred Tax Assets, Operating Loss Carryforwards in USD of Core Laboratories Inc. /DE/ from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Core Laboratories Inc. /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q4 2022 to Q4 2024.
  • Core Laboratories Inc. /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $6.28M, a 19.6% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Core Laboratories Inc. /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $6.28M -$1.54M -19.6% 31 Dec 2024 10-K 13 Feb 2025
Q4 2023 $7.81M -$5.28M -40.3% 31 Dec 2023 10-K 13 Feb 2025
Q4 2022 $13.1M 31 Dec 2022 10-K 15 Feb 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.